‘Evonik investment gives us a lot of credibility,’ says CEO of an algae feed firm that aims to could cut reliance on antibiotics
Evonik, as part of an investors’ consortium, has announced its backing of a microalgae derived beta-glucan that is said to support immune health for animals and could help the sector migrate away from over usage of antibiotics.